NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11739-022-02933-x.pdf
Reference32 articles.
1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA [Internet]. 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585
2. World Health Organization. Situation Reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed Jun 2021
3. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N et al (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis [Internet]. 20(6):669–677. https://doi.org/10.1016/S1473-3099(20)30243-7
4. Ruan S (2020) Likelihood of survival of coronavirus disease 2019. Lancet Infect Dis [Internet]. 20(6):630–631. https://doi.org/10.1016/S1473-3099(20)30257-7
5. Kass DA, Duggal P, Cingolani O (2020) Obesity could shift severe COVID-19 disease to younger ages. Lancet (London, England). 395:1544–1545
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review;World Journal of Hepatology;2024-08-27
2. CT attenuation values predict liver injury in COVID-19 patients;Egyptian Journal of Radiology and Nuclear Medicine;2024-08-09
3. Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial;Scientific Reports;2024-05-14
4. Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?;Journal of Clinical Medicine;2024-05-03
5. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3